EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO)



Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO)



Toxicology 225(2-3): 195-203



The relationship between age and plasma concentration of perfluorooctanoate (PFOA) in young rats was investigated. The study was conducted in two phases in which male and female rats between 3 and 8 weeks of age were administered the ammonium salt of PFOA (APFO) by single oral gavage at either 10 or 30 mg/kg. In Phase 1, APFO was administered at a dose of 10 mg/kg body weight to 27-, 34-, 38-,48-, and 55-day-old male and female rats. Plasma was collected 24 It after the dose. In Phase 11, APFO doses of either 10 or 30 mg/kg body weight were given to groups of 23-, 30-, and 32-day-old male and female rats, and plasma was collected at 2 and 24 h after the dose (separate groups), and urine was collected for 24 h. PFOA concentrations were measured by LC/MS/MS. In Phase 1, plasma concentrations of PFOA were not dependent on age for rats 5 weeks of age and older; however, in 4-week-old rats, male plasma PFOA concentrations were 5-6 times lower than during weeks 5-8, and female plasma PFOA concentrations were 2.5-4 times higher than subsequent weeks. In Phase 11, plasma samples collected 2 h post-dosing indicated no significant difference in the PFOA uptake by age in females; although, in males, plasma PFOA concentrations were significantly less in 32-day-old rats, approximating one-half of the values observed at 23 and 30 days of age. Plasma samples collected 24 It after dosing from 3- to 5-week-old rats indicated a slightly but significantly higher male plasma concentration at 30 and 32 days of age as compared to 23 days of age for the 30 mg/kg dose group only. Significantly lower (approximately 10-fold) plasma PFOA concentrations occurred in 32-day-old females as compared with 23- and 30-day-old females at both 2 and 24 It after the dose. Although statistically significant changes in urine PFOA concentrations did not occur between age and dose groups within sex, urine PFOA concentrations generally supported plasma elimination. At 23 days of age, the ratio of male to female plasma PFOA concentrations was approximately 2-3:1 compared to approximately 30:1 at 32 days of age. An unexplainable inconsistency in PFOA plasma concentrations for both sexes was noted when comparing Phase I values for 27-day-old rats to Phase 11 values for 23- and 30-day-old rats. The Phase I values for the 27-day-old rats of both sexes were five to six times lower than Phase 11 values for the 23- and 30-day-old rats. However, Phase I values for 34-day-old rats were comparable to Phase 11 values for 32-day-old rats. Despite this anomaly between the 23-, 27-, and 30-day-old rat values, there is strong evidence that age-dependent changes in the elimination of PFOA develop in female rats between 3 and 5 weeks of age, with a consistent marked difference occurring after 30 days of age. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

(PDF emailed within 0-6 h: $19.90)

Accession: 011735439

Download citation: RISBibTeXText

PMID: 16857306

DOI: 10.1016/j.tox.2006.06.002



Related references

Serum perfluorooctanoic acid (PFOA) concentrations in normal and hyperlipidemic female hamsters dosed orally with ammonium perfluorooctanoate (APFO) for up to 30 days. Toxicology Reports 2: 70-77, 2015

Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species. Drug and Chemical Toxicology 29(2): 137-145, 2006

13-week dietary toxicity study of ammonium perfluorooctanoate (APFO) in male rats. Drug and Chemical Toxicology 27(4): 361-378, 2004

The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 196(1-2): 95-116, 2004

Pathology Working Group review and evaluation of proliferative lesions of mammary gland tissues in female rats fed ammonium perfluorooctanoate (APFO) in the diet for 2 years. Drug and Chemical Toxicology 33(2): 131-137, 2010

The embryo-fetal toxicity and teratogenic potential of ammonium perfluorooctanoate (APFO) in the rat. Fundamental and Applied Toxicology 4(3 Pt 1): 429-440, 1984

Acute and chronic aquatic toxicity of ammonium perfluorooctanoate (APFO) to freshwater organisms. Ecotoxicology and Environmental Safety 71(3): 749-756, 2008

Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). Toxicology 220(2-3): 203-217, 2006

Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. Journal of Occupational and Environmental Medicine 49(10): 1086-1096, 2007

Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure. Environmental Health Perspectives 120(5): 655-660, 2012

Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environmental Research 103(2): 176-184, 2006

Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats. Fundamental and Applied Toxicology 30(2): 220-228, 1996

Effect of the Peroxisome Proliferator, Ammonium Perfluorooctanoate (C8), on Hepatic Aromatase Activity in Adult Male CrI:CD BR (CD) Rats. Toxicological Sciences 30(2): 220-228, 1996

Effect of the peroxisome proliferator, ammonium perfluorooctanoate , on hepatic aromatase activity in adult male CrlCD BR rats. Fundamental & Applied Toxicology 30(2): 220-228, 1996

Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water. Environmental Health Perspectives 120(5): 752-757, 2012